Dividend Daily Flow
  • Business
  • World News
  • Investing
  • Stock
World News

Jackson’s scathing dissent levels partisan charge at colleagues after high-profile ruling

by admin August 23, 2025
August 23, 2025

Justice Ketanji Brown Jackson criticized on Thursday what she said were the ‘recent tendencies’ of the Supreme Court to side with the Trump administration, providing her remarks in a bitter dissent in a case related to National Institutes of Health grants.

Jackson, a Biden appointee, rebuked her colleagues for ‘lawmaking’ on the shadow docket, where an unusual volume of fast, preliminary decision-making has taken place related to the hundreds of lawsuits President Donald Trump’s administration has faced.

‘This is Calvinball jurisprudence with a twist. Calvinball has only one rule: There are no fixed rules. We seem to have two: that one, and this Administration always wins,’ Jackson wrote.

The liberal justice pointed to the Oxford English Dictionary’s definition of Calvinball, which describes it as the practice of applying rules inconsistently for self-serving purposes.

Jackson, the high court’s most junior justice, said the majority ‘[bent] over backwards to accommodate’ the Trump administration by allowing the NIH to cancel about $783 million in grants that did not align with the administration’s priorities.

Some of the grants were geared toward research on diversity, equity and inclusion; COVID-19; and gender identity. Jackson argued the grants went far beyond that and that ‘life-saving biomedical research’ was at stake.

‘So, unfortunately, this newest entry in the Court’s quest to make way for the Executive Branch has real consequences, for the law and for the public,’ Jackson wrote.

The Supreme Court’s decision was fractured and only a partial victory for the Trump administration.

In a 5-4 decision greenlighting, for now, the NIH’s existing grant cancellations, Chief Justice John Roberts sided with the three liberal justices. In a second 5-4 decision that keeps a lower court’s block on the NIH’s directives about the grants intact, Justice Amy Coney Barrett, a Trump appointee, sided with Roberts and the three liberals. The latter portion of the ruling could hinder the NIH’s ability to cancel future grants.

The varying opinions by the justices came out to 36 pages total, which is lengthy relative to other emergency rulings. Jackson’s dissent made up more than half of that.

George Washington University law professor Jonathan Turley observed in an op-ed last month a rise in ‘rhetoric’ from Jackson, who garnered a reputation as the most vocal justice during oral arguments upon her ascension to the high court.

‘The histrionic and hyperbolic rhetoric has increased in Jackson’s opinions, which at times portray her colleagues as abandoning not just the Constitution but democracy itself,’ Turley said.

Barrett had sharp words for Jackson in a recent highly anticipated decision in which the Supreme Court blocked lower courts from imposing universal injunctions on the government. Barrett accused Jackson of subscribing to an ‘imperial judiciary’ and instructed people not to ‘dwell’ on her colleague’s dissent.

Barrett, the lone justice to issue the split decision in the NIH case, said challenges to the grants should be brought by the grant recipients in the Court of Federal Claims.

But Barrett said ‘both law and logic’ support that the federal court in Massachusetts does have the authority to review challenges to the guidance the NIH issued about grant money. Barrett joined Jackson and the other three in denying that portion of the Trump administration’s request, though she said she would not weigh in at this early stage on the merits of the case as it proceeds through the lower courts.

Jackson was dissatisfied with this partial denial of the Trump administration’s request, saying it was the high court’s way of preserving the ‘mirage of judicial review while eliminating its purpose: to remedy harms.’

This post appeared first on FOX NEWS

previous post
GOP senators push Kamala Harris testimony as House Oversight eyes subpoena
next post
10 key takeaways from DOJ’s release of Ghislaine Maxwell’s Epstein interviews

You may also like

Trump touts 5-0 sweep by endorsed candidates in...

March 12, 2026

DAVID MARCUS: Sen Thune has no idea how...

March 12, 2026

Cornyn reverses on filibuster stance to push Trump’s...

March 12, 2026

US destroys 16 Iranian mine boats as Strait...

March 12, 2026

House GOP urges Trump to choke off Iran...

March 12, 2026

US strike on key Iran oil hub would...

March 11, 2026

DOJ blasts ‘partisan’ DC Bar complaint against senior...

March 11, 2026

Putin caught executing enormous ‘semi-dark’ ship-to-ship oil transfer...

March 11, 2026

Rubio designates Afghanistan as ‘state sponsor of wrongful...

March 11, 2026

Speaker Johnson touts Trump’s agenda as crucial blueprint...

March 11, 2026

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Business News

    • United Airlines says it will boot passengers who refuse to use headphones on planes

      March 7, 2026
    • DOJ takes Live Nation-Ticketmaster to court for antitrust trial

      March 5, 2026
    • L.A. County sues Roblox, alleges platform makes it easy for adults to target children

      February 22, 2026
    • Warner Bros. Discovery reopens talks with Paramount

      February 19, 2026
    • CFTC chief sides with prediction markets over state regulators in a high-stakes court case

      February 19, 2026
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: dividenddailyflow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 dividenddailyflow.com | All Rights Reserved

    Dividend Daily Flow
    • Business
    • World News
    • Investing
    • Stock